• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Authors Posts by admin

admin

2176 POSTS 0 COMMENTS
https://psynews.com

No, VR Will Not Give You A Psychedelic Trip

PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year...

Danish And British Startups Partner to Bring Innovative Psychedelics to Patients

Glutamate’s Role in Rapidly-Acting Antidepressants

Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its...

Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in...

Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes

Filament Health Shares to Commence Trading on the OTC Market

Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical...

PT261 – Dr. Tiago Reis Marques – Ketamine, New Drugs, and...

1...199200201...218Page 200 of 218

EDITOR PICKS

Toad, Truth, and the Trouble with 5-MeO: Why Bufo alvarius Needs...

One Year After FDA’s MDMA Rejection: Insiders and Observers Reflect

Harry Pack NFT – Last Call

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©